Search Results - "Birkhofer, Martin J."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    A Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men by Gajjar, Diptee A., LaCreta, Frank P., Uderman, Howard D., Kollia, Georgia D., Duncan, Glenn, Birkhofer, Martin J., Grasela, Dennis M.

    Published in Pharmacotherapy (01-06-2000)
    “…Study Objectives. To examine single‐ and multiple‐dose safety, tolerability and pharmacokinetics of gatifloxacin administered as daily 1‐hour intravenous…”
    Get full text
    Journal Article
  2. 2

    CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris by Abrams, J R, Lebwohl, M G, Guzzo, C A, Jegasothy, B V, Goldfarb, M T, Goffe, B S, Menter, A, Lowe, N J, Krueger, G, Brown, M J, Weiner, R S, Birkhofer, M J, Warner, G L, Berry, K K, Linsley, P S, Krueger, J G, Ochs, H D, Kelley, S L, Kang, S

    Published in The Journal of clinical investigation (01-05-1999)
    “…Engagement of the B7 family of molecules on antigen-presenting cells with their T cell-associated ligands, CD28 and CD152 (cytotoxic T lymphocyte-associated…”
    Get full text
    Journal Article
  3. 3

    Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer by MEROPOL, N. J, SONNICHSEN, D. S, BIRKHOFER, M. J, FERREIRA, I, NOEL, D

    “…This study was undertaken to address the influence of concurrent administration on the pharmacokinetics of UFT (uracil plus tegafur) and leucovorin (LV), and…”
    Get full text
    Journal Article